Back to
Renaissance Technologies LLC
DRUG
Showing 0 of 3 quarters
Position history for
Renaissance Technologies LLC's holdings in BRIGHT MINDS BIOSCIENCES INC
No. Renaissance Technologies exited its DRUG (Bright Minds Biosciences) position in Q3 2023. Its Q2 2023 13F listed 11,200 shares worth $6,000. Renaissance Technologies first reported DRUG in Q1 2023 and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.